Utilization of EGFR, ALK, and BRAF Inhibitors in the Treatment of Lung Cancer in Germany
ABSTRACT Background There is a lack of real‐world data on the use of targeted cancer drugs requiring molecular tumor diagnostics in the treatment of lung cancer in Germany. Aims We aimed to characterize the use of such drugs in lung cancer patients based on longitudinal analyses. Methods and Results...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70060 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!